SPOTLIGHT -
Slideshow
Author(s):
Can dietary supplementation decrease the risk of transition to psychosis?
Clinical Pearls: Treating Trauma and Psychosis
Treating ‘Morally Objectionable’ Patients
Peter J. Weiden, MD, Discusses Clozapine REMS Challenges and Advisory Committees' Recommendations
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
FDA Committees Vote to Dismiss Clozapine REMS
Beyond Dopamine: Muscarinic Solutions Bring New Hope for Schizophrenia